
What to track first if you actually want to optimize healthspan
The short list of signals that move the needle — and the ones safe to ignore for now.
Longevity.Technology is a media and briefing platform covering longevity science, investment, innovation, clinics, and ecosystem developments.
People who want to follow longevity science, startups, investment, innovation, clinics, and market developments.
These are editorial signals, not endorsements. Always pair with qualified medical guidance.
A short due-diligence list to apply before paying, booking, subscribing, or building a routine around any longevity tool, test, or program.
What exactly will this measure, track, or improve — and over what time horizon?
Is there medical or clinician oversight, and how qualified are the people behind it?
How should I interpret the data, and what does a meaningful change actually look like?
What will I do differently with the results? If the answer is unclear, the signal isn't useful yet.
Is the claim evidence-led or marketing-led? Where is the underlying research?
What is the true cost after the first purchase, test, or subscription — including renewals?
Does this replace medical advice? It should not. Where does professional care still belong?
How does this compare to simpler, lower-cost, or higher-evidence alternatives?
Huberman Lab is a science and health podcast covering neuroscience, performance, sleep, stress, learning, and behavior change.
Buck Institute is a biomedical research institution focused on the biology of aging and age-related disease.
Stanford Center on Longevity advances research, education, and public engagement around longer, healthier, more purposeful lives.
USC Longevity Institute focuses on translational research on aging, longevity, nutrition, fasting, and age-related disease.
A4M LongevityFest is a longevity medicine conference for clinicians, physicians, innovators, and health professionals.
Media and market coverage can be useful for discovery, but users should distinguish reporting, investment interest, and commercial momentum from clinical proof.

The short list of signals that move the needle — and the ones safe to ignore for now.

A direct comparison of recovery, strain, sleep, and fitness signal — without the influencer noise.

ApoB, ferritin, hormones, inflammation — the markers worth knowing, and how to read them.